The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations-Reference-Cited by-同舟云学术

The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations

Published:2024-02-01 Issue:5 Volume:93 Page:481-496
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Ma Xiaoya,Li Yujie,Zang Xufeng,Guo Jinping,Zhou Wenqian,Han Junhui,Liang Jing,Wan Panpan,Yang Hua,Jin Tianbo^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00280-023-04638-0.pdf

Reference43 articles.

1. Montané E, Santesmases J (2020) Adverse drug reactions. Med Clin (Barc) 154(5):178–184. https://doi.org/10.1016/j.medcli.2019.08.007

2. Langmia IM, Just KS, Yamoune S et al (2021) CYP2B6 functional variability in drug metabolism and exposure across populations-implication for drug safety, dosing, and individualized therapy. Front Genet 12:692234. https://doi.org/10.3389/fgene.2021.692234

3. Pirmohamed M (2023) Pharmacogenomics: current status and future perspectives. Nat Rev Genet 24(6):350–362. https://doi.org/10.1038/s41576-022-00572-8

4. Zhang H, De T, Zhong Y et al (2019) The advantages and challenges of diversity in pharmacogenomics: can minority populations bring us closer to implementation? Clin Pharmacol Ther 106(2):338–349. https://doi.org/10.1002/cpt.1491

5. Danese E, Raimondi S, Montagnana M et al (2019) Effect of CYP4F2, VKORC1, and CYP2C9 in influencing coumarin dose: a single-patient data meta-analysis in more than 15,000 individuals. Clin Pharmacol Ther 105(6):1477–1491. https://doi.org/10.1002/cpt.1323